Cite
HARVARD Citation
Saberian, C. et al. (2021). Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation. Journal for immunotherapy of cancer. 9 (2), p. . [Online].